Abstract
Purpose
Little is known about cancer survivors’ receptivity to being contacted through cancer registries for research and health promotion efforts. We sought to (1) determine breast and colorectal cancer (CRC) survivors’ responsiveness to a mailed survey using an academic medical center’s cancer registry, (2) assess whether responsiveness varied according to sociodemographic characteristics and medical history, and (3) examine the prevalence and correlates of respondents’ awareness and willingness to be contacted through the state cancer registry for future research studies.
Methods
Stage 0–III breast and CRC survivors diagnosed between January 2004 and December 2009 were identified from an academic medical center cancer registry. Survivors were mailed an invitation letter with an opt-out option, along with a survey assessing sociodemographic characteristics, medical history, and follow-up cancer care access and utilization.
Results
A total of 452 (31.4 %) breast and 53 (22.2 %) CRC survivors responded. Willingness to be contacted through the state cancer registry was high among both breast (74 %) and CRC (64 %) respondents even though few were aware of the registry and even fewer knew that their information was in the registry. In multivariable analyses, tumor stage I and not having a family history of cancer were associated with willingness among breast and CRC survivors, respectively.
Conclusions
Our findings support the use of state cancer registries to contact survivors for participation in research studies.
Implications for Cancer Survivors
Survivors would benefit from partnerships between researchers and cancer registries that are focused on health promotion interventions.
Similar content being viewed by others
References
American Cancer Society. Cancer Treatment and Survivorship Facts & Figures 2012–2013. Last update 2012. a-42. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-033876.pdf. Accessed 18 June 2012.
Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103:117–28. doi:10.1093/jnci/djq495.
Hewitt M, Greenfield SSE. From cancer patient to cancer survivor: lost in transition. Washington: National Academies; 2005.
Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41. doi:10.3322/caac.21149.
Lash TL, Fox MP, Buist DS, Wei F, Field TS, Frost FJ, Geiger AM, Quinn VP, Yood MU, Silliman RA. Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol. 2007;25:3001–6. doi:10.1200/JCO.2006.09.9572.
Cooper GS, Kou TD, Reynolds Jr HL. Receipt of guideline-recommended follow-up in older colorectal cancer survivors: a population-based analysis. Cancer. 2008;113:2029–37. doi:10.1002/cncr.23823.
Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007;50:1783–99. doi:10.1007/s10350-007-9030-5.
Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007. CD002200. doi:10.1002/14651858.CD002200.pub2
Breslau ES, Jeffery DD, Davis WW, Moser RP, McNeel TS, Hawley S. Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California health interview survey. J Cancer Surviv. 2010;4:1–14. doi:10.1007/s11764-009-0102-5.
Carcaise-Edinboro P, Bradley CJ, Dahman B. Surveillance mammography for Medicaid/Medicare breast cancer patients. J Cancer Surviv. 2010;4:59–66. doi:10.1007/s11764-009-0107-0.
Doubeni CA, Field TS, Ulcickas Yood M, Rolnick SJ, Quessenberry CP, Fouayzi H, Gurwitz JH, Wei F. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006;106:2482–8. doi:10.1002/cncr.21893.
Duffy CM, Clark MA, Allsworth JE. Health maintenance and screening in breast cancer survivors in the United States. Cancer Detect Prev. 2006;30:52–7. doi:10.1016/j.cdp.2005.06.012.
Elston Lafata J, Simpkins J, Schultz L, Chase GA, Johnson CC, Yood MU, Lamerato L, Nathanson D, Cooper G. Routine surveillance care after cancer treatment with curative intent. Med Care. 2005;43:592–9. doi:10.1097/01.mlr.0000163656.62562.c4.
Field TS, Doubeni C, Fox MP, Buist DS, Wei F, Geiger AM, Quinn VP, Lash TL, Prout MN, Yood MU, Frost FJ, Silliman RA. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008;23:158–63. doi:10.1007/s11606-007-0471-2.
Geller BM, Kerlikowske K, Carney PA, Abraham LA, Yankaskas BC, Taplin SH, Ballard-Barbash R, Dignan MB, Rosenberg R, Urban N, Barlow WE. Mammography surveillance following breast cancer. Breast Cancer Res Treat. 2003;81:107–15. doi:10.1023/A:1025794629878.
Katz ML, Donohue KA, Alfano CM, Day JM, Herndon JE, Paskett ED. Cancer surveillance behaviors and psychosocial factors among long-term survivors of breast cancer. Cancer and Leukemia Group B 79804. Cancer. 2009;115:480–8. doi:10.1002/cncr.24063.
Khan NF, Carpenter L, Watson E, Rose PW. Cancer screening and preventative care among long-term cancer survivors in the United Kingdom. Br J Cancer. 2010;102:1085–90. doi:10.1038/sj.bjc.6605609.
Andersen MR, Urban N. The use of mammography by survivors of breast cancer. Am J Public Health. 1998;88:1713–5. doi:10.2105/AJPH.88.11.1713.
Boehmer U, Harris J, Bowen DJ, Schroy III PC. Surveillance after colorectal cancer diagnosis in a safety net hospital. J Health Care Poor Underserved. 2010;21:1138–51.
Cooper GS, Payes JD. Temporal trends in colorectal procedure use after colorectal cancer resection. Gastrointest Endosc. 2006;64:933–40. doi:10.1016/j.gie.2006.08.024.
Ellison GL, Warren JL, Knopf KB, Brown ML. Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res. 2003;38:1885–903. doi:10.1111/j.1475-6773.2003.00207.x.
Elston Lafata J, Cole JC, Ben-Menachem T, Morlock RJ. Sociodemographic differences in the receipt of colorectal cancer surveillance care following treatment with curative intent. Med Care. 2001;39:361–72. doi:10.1097/00005650-200104000-00007.
Foley KL, Song EY, Klepin H, Geiger A, Tooze J. Screening colonoscopy among colorectal cancer survivors insured by Medicaid. Am J Clin Oncol. 2012;35:205–11. doi:10.1097/COC.0b013e318209d21e.
Jackson GL, Melton LD, Abbott DH, Zullig LL, Ordin DL, Grambow SC, Hamilton NS, Zafar SY, Gellad ZF, Kelley MJ, Provenzale D. Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs. J Clin Oncol. 2010;28:3176–81. doi:10.1200/JCO.2009.26.7948.
Rolnick S, Alford SH, Kucera GP, Fortman K, Yood MU, Jankowski M, Johnson CC. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Cancer Inst Monogr. 2005;2005:96–101. doi:10.1093/jncimonographs/lgi045.
Rulyak SJ, Mandelson MT, Brentnall TA, Rutter CM, Wagner EH. Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer. Gastrointest Endosc. 2004;59:239–47. doi:10.1016/S0016-5107(03)02531-8.
Grunfeld E, Hodgson DC, Del Giudice ME, Moineddin R. Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract. 2010;6:174–81. doi:10.1200/JOP.200009.
Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol. 2007;25:1074–81. doi:10.1200/JCO.2006.08.6876.
Sankila R, Martinez C, Parkin DM, Storm H, Teppo L. Informed consent in cancer registries. Lancet. 2001;357:1536. doi:10.1016/S0140-6736(00)04699-7.
Beskow LM, Sandler RS, Weinberger M. Research recruitment through US central cancer registries: balancing privacy and scientific issues. Am J Public Health. 2006;96:1920–6. doi:10.2105/AJPH.2004.061556.
AJCC. AJCC Cancer Staging Manual. 6th ed. Chicago: American Joint Committee on Cancer; 2002.
Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley; 2000.
Newcomb PA, Love RR, Phillips JL, Buckmaster BJ. Using a population-based cancer registry for recruitment in a pilot cancer control study. Prev Med. 1990;19:61–5. doi:10.1016/0091-7435(90)90008-8.
Sugarman J, Regan K, Parker B, Bluman LG, Schildkraut J. Ethical ramifications of alternative means of recruiting research participants from cancer registries. Cancer. 1999;86:647–51. doi:10.1002/(SICI)1097-0142(19990815)86:4<647::AID-CNCR13>3.0.CO;2-G.
Pakilit AT, Kahn BA, Petersen L, Abraham LS, Greendale GA, Ganz PA. Making effective use of tumor registries for cancer survivorship research. Cancer. 2001;92:1305–14. doi:10.1002/1097-0142(20010901)92:5<1305::AID-CNCR1452>3.0.CO;2-M.
Rogerino A, Grant LL, Wilcox III H, Schmitz KH. Geographic recruitment of breast cancer survivors into community-based exercise interventions. Med Sci Sports Exerc. 2009;41:1413–20. doi:10.1249/MSS.0b013e31819af871.
Boehmer U, Clark M, Glickman M, Timm A, Sullivan M, Bradford J, Bowen DJ. Using cancer registry data for recruitment of sexual minority women: successes and limitations. J Women's Health. 2010;19:1289–97. doi:10.1089/jwh.2009.1744.
Pal T, Rocchio E, Garcia A, Rivers D, Vadaparampil S. Recruitment of black women for a study of inherited breast cancer using a cancer registry-based approach. Genet Test Mol Biomarkers. 2011;15:69–77. doi:10.1089/gtmb.2010.0098.
Kelly BJ, Fraze TK, Hornik RC. Response rates to a mailed survey of a representative sample of cancer patients randomly drawn from the Pennsylvania Cancer Registry: a randomized trial of incentive and length effects. BMC Med Res Methodol. 2010;10:65. doi:10.1186/1471-2288-10-65.
Salsman JM, Segerstrom SC, Brechting EH, Carlson CR, Andrykowski MA. Posttraumatic growth and PTSD symptomatology among colorectal cancer survivors: a 3-month longitudinal examination of cognitive processing. Psychooncology. 2009;18:30–41. doi:10.1002/pon.1367.
Lowery JT, Axell L, Vu K, Rycroft R. A novel approach to increase awareness about hereditary colon cancer using a state cancer registry. Genet Med. 2010;12:721–5. doi:10.1097/GIM.0b013e3181f1366a.
Kaiser K. The meaning of the survivor identity for women with breast cancer. Soc Sci Med. 2008;67:79–87. doi:10.1016/j.socscimed.2008.03.036.
Jacobsen GD, Jacobsen KH. Health awareness campaigns and diagnosis rates: evidence from National Breast Cancer Awareness Month. J Health Econ. 2011;30:55–61. doi:10.1016/j.jhealeco.2010.11.005.
Harvey JA, Strahilevitz MA. The power of pink: cause-related marketing and the impact on breast cancer. J Am Coll Radiol. 2009;6:26–32. doi:10.1016/j.jacr.2008.07.010.
Williamson JM, Jones IH, Hocken DB. How does the media profile of cancer compare with prevalence? Ann R Coll Surg Engl. 2011;93:9–12. doi:10.1308/003588411X12851639106954.
Beskow LM, Sandler RS, Millikan RC, Weinberger M. Patient perspectives on research recruitment through cancer registries. Cancer Causes Control. 2005;16:1171–5. doi:10.1007/s10552-005-0407-2.
Ramirez AG, Miller AR, Gallion K, de MS SM, Chalela P, Garcia AS. Testing three different cancer genetics registry recruitment methods with Hispanic cancer patients and their family members previously registered in local cancer registries in Texas. Community Genet. 2008;11:215–23. doi:10.1159/000116882.
Acknowledgments
This study was funded by the Moncrief Cancer Institute. Funding from the National Institutes of Health/National Cancer Institute supported MYC (K07CA140159) and SWV (R01CA112223). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Moncrief Cancer Institute, the National Cancer Institute.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carpentier, M.Y., Tiro, J.A., Savas, L.S. et al. Are cancer registries a viable tool for cancer survivor outreach? A feasibility study. J Cancer Surviv 7, 155–163 (2013). https://doi.org/10.1007/s11764-012-0259-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-012-0259-1